Back
Aclaris Therapeutics Vs. John Wiley & Sons Industry Stock Comparison
Sell
22
ACRS
Aclaris Therapeutics
Last Price:
1.13
Seasonality Move:
-8.1%
Sell
50
WLY
John Wiley & Sons
Last Price:
39.98
Seasonality Move:
1.04%
Sell
22
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.13. The Score for ACRS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
John Wiley & Sons (WLY)
is a Sell
Is John Wiley & Sons a Buy, Sell or Hold?
- The current John Wiley & Sons [WLY] share price is $39.98. The Score for WLY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- WLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.13
The current trend is relatively stagnant and ACRS is experiencing slight selling pressure.
WLY Stock Price Chart
What is John Wiley & Sons's stock price today?
-
The John Wiley & Sons share price today is $39.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 50.43 | Buy |
| Chaikin Money Flow: | -214047 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.18) | Buy |
| Bollinger Bands (100): | (1.11 - 1.27) | Sell |
WLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 64.17 | Buy |
| Chaikin Money Flow: | 218284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.95 - 38.91) | Buy |
| Bollinger Bands (100): | (34.48 - 38.58) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Buy |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.17 | Sell |
| 200-day SMA: | 2.42 | Sell |
| 8-day EMA: | 1.12 | Buy |
| 20-day EMA: | 1.12 | Buy |
| 50-day EMA: | 1.16 | Sell |
| 200-day EMA: | 2.9 | Sell |
WLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.53 | Buy |
| 20-day SMA: | 37.19 | Buy |
| 50-day SMA: | 37.74 | Buy |
| 200-day SMA: | 34.52 | Buy |
| 8-day EMA: | 38.3 | Buy |
| 20-day EMA: | 37.61 | Buy |
| 50-day EMA: | 37.35 | Buy |
| 200-day EMA: | 36.04 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.
John Wiley & Sons Earnings Growth & WLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.51 per share, a decrease next quarter of $0.23 per share, a decrease this year of $1.00 per share, and an increase next year of $1.00 per share.
Aclaris Therapeutics Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
John Wiley & Sons Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||